Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2022-10-14 00:00:00 ET · period of report 2022-10-12 · accession 0001209191-22-053647 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-14 | 2022-10-12 | RARE | Dier Mardi | CFO, EVP | S - Sale | $38.22 | -3,484 | 68.3K | -5% | -$133.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-12 | S | D | 3,484 | $38.22 | 68,324 | D | — | — | (F2) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |